Industrial, Manufacturing & Heavy Industry Market News

Learn details of the hypertension pipeline market

Report Reviews Latest Drugs and Company Projects H1 2017

- Agency -.

Hypertension Pipeline H1 2017, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

Key players of Hypertension Pipeline Report are A1M Pharma AB, Actelion Ltd, Alnylam Pharmaceuticals Inc, Anacor Pharmaceuticals Inc, AnGes MG Inc, Arena Pharmaceuticals Inc, Ascendis Pharma A/S, Asklepion Pharmaceuticals LLC, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc.

Access Report On Hypertension Pipeline Review H1 2017: www.rnrmarketresearch.com/contacts/?rname=1066604 .

Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure.

- Agency -.

Many factors can affect blood pressure, including hormone levels, water and salt levels in body and condition of kidneys, nervous system, or blood vessels.

Most people with high blood pressure have no signs or symptoms, even if blood pressure readings reach dangerously high levels. Although a few people with early-stage high blood pressure may have dull headaches, dizzy spells or a few more nosebleeds than normal, these signs and symptoms typically don't occur until high blood pressure has reached a severe.

Report: www.rnrmarketresearch.com/contacts/?rname=1066604 .

The Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 7, 35, 35, 31, 89, 9 and 1 respectively.

Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 24 and 11 molecules, respectively.

Scope

The report provides a snapshot of the global therapeutic landscape of Hypertension. The report reviews pipeline therapeutics for Hypertension by companies and universities/research institutes based on information derived from company and industry-specific sources.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Hypertension therapeutics and enlists all their major and minor projects. The report assesses Hypertension therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Hypertension

Hypertension pipeline (Cardiovascular) guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

List of Figures
Number of Products under Development for Hypertension, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

 

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.